Palavras-chave
carcinoma de pulmón de células no pequeñas
consolidación
pulmonar
fibrosis pulmonar
Como Citar
Resumo
En la última década, la radioterapia estereotáctica corporal se ha implementado como tratamiento a pacientes con cáncer de pulmón estadio I, quienes son considerados inoperables o quienes rechazan el procedimiento quirúrgico. El artículo presenta el caso de uno de los primeros pacientes tratados con esta tecnología en un centro oncológico: un hombre de 72 años de edad con cáncer de pulmón estadio I, quien rechazó el manejo quirúrgico y se le realizó el tratamiento con radiocirugía, y con dos años de seguimiento, presentó cambios radiográficos, que inicialmente se interpretaron como progresión de la enfermedad. Además, se revisa la literatura relacionada con la interpretación de imágenes de seguimiento después del tratamiento.
Crabtree TD, Denlinger CE, Meyers BF,
El Naqa I, Zoole J, Krupnick AS, et al.
Stereotactic body radiation therapy versus
surgical resection for stage I nonsmall
cell lung cancer. J Thorac Cardiovasc
Surg. 2010;140:377-86.
Timmerman R, Paulus R, Galvin J, Michalski
J, Straube W, Bradley J, et al.
Stereotactic body radiation therapy
for inoperable early stage lung cancer.
JAMA. 2010;303:1070-6.
Timmerman R, McGarry R, Yiannoutsos
C, Papiez L, Tudor K, DeLuca J, et al.
Excessive toxicity when treating central
tumors in a phase II study of stereotactic
body radiation therapy for medically inoperable
early-stage lung cancer. J Clin
Oncol. 2006;24:4833-9.
Rowe BP, Boffa DJ, Wilson LD, Kim
AW, Detterbeck FC, Decker RH. Stereotactic
body radiotherapy for central lung
tumors. J Thorac Oncol. 2012;7:1394-9.
Mountain CF. A new international staging
system for lung cancer. Chest.
;89:225S-33S.
Coy P, Kennelly GM. The role of curative
radiotherapy in the treatment of lung
cancer. Cancer. 1980;45:698-702.
Chang BK, Timmerman RD. Stereotactic
body radiation therapy: a comprehensive
review. Am J Clin Oncol.
;30(6):637-44.
Joanne ND, Clinton M, Sanjeev S. Stereotactic
body radiotherapy for centrally
located early-stage non-small cell lung
cancer or lung metastases from the RSSearch
® patient registry. Radiation Oncol.
;10:113.
DeRose F, Cozzi L, Navarria P, Ascolese
AM, Clerici E, Infante E, et al. Clinical
outcome of stereotactic ablative body radiotherapy
for lung metastatic lesions in
non-small cell lung cancer oligometastatic
patients. Clin Oncol. 2016;28(1):13-
doi: 10.1016/j.clon.2015.08.011
Ligang X, Yong Y, Spring K. Survey of
stereotactic body radiation oncology for early staged non-small cell lung cancer
in china. Int J Med Phys Clin Eng Radiat
Oncolo. 2014;3(1):56-9. doi: 10.4236/
ijmpcero.2014.31009
Yu JB, Soulos PR, Cramer LD, Decker
RH, Kim AW, Gross CP. Comparative effectiveness
of surgery and radiosurgery
for stage i non-small cell lung cancer.
Cancer. 2015 Jul;121(14):2341-9. doi:
1002/cncr.29359
Verstegen NE, Lagerwaard FJ, Haasbeek
CJ, et al. Outcomes of stereotactic ablative
radiotherapy following a clinical
diagnosis of stage I NSCLC: Comparison
with a contemporaneus cohort with
pathologically proven disease. Radiother
Oncol. 2011;101: 250-4.
Nanda RH, Liu Y, Gillespie TW, Mikell
JL, Ramalingam SS, Fernandez FG, et
al. Stereotactic body radiation therapy
versus no treatment for early stage
non-small cell lung cancer in medically
inoperable elderly patients: A National
Cancer Data Base Analysis. Cancer.
;121(23):4222-30.
Timmerman R, Papiez L, McGarry R, et
al. Extracranial stereotactic radioablation:
Results of a phase I study in medically
inoperable stage I non - small cell
lung cancer. Chest. 2003;124:1946-55.
Franks P, Jain MP. Stereotactic ablative
body radiotherapy for lung cancer. Clin
Oncol. 2015;27:280–9.
Pennathur A, Luketich JD, Heron DE,
Schuchert MJ, Bianco V, Clump D, Burton
S. Stereotactic radiosurgery/stereotactic
body radiotherapy for recurrent
lung neoplasm: An analysis of outcomes
in 100 patients. Ann Thorac Surg.
;100(6):2019-24.
Kelley DL, Benninghoff JS. Medically
inoperable peripheral lung cancer treated
with stereotactic body radiation therapy.
Radiat Oncol. 2015;10:120.
Fukumoto S, Shirato H, Shimzu S et
al. Small-volume image-guided radiotherapy
using hypofractionated, coplanar,
and noncoplanar multiple fields
for patients with inoperable Stage I
nonsmall cell lung carcinomas. Cancer.
;95:1546-53.
Timmerman R, Papiez L, McGarry R, et
al. Extracranial stereotactic radioablation:
results of a phase I study in medically
inoperable stage I non - small cell
lung cancer. Chest. 2003;124:1946-55.
Hoopes DJ, Fletcher J, Tann M, et al. A
prospective trial of serial FDG-PET in
patients with medically inoperable stage
I non-small cell lung cancer treated with
hypofractionated stereotactic body radiotherapy
(SBRT). ASTRO. 2006;66:825-6.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.